Skip to main content
The British Journal of Cancer. Supplement logoLink to The British Journal of Cancer. Supplement
. 1980 Apr;4:74–78.

In situ drug delivery.

V A Levin, D C Wright, H D Landahl, C S Patlak, J Csejtey
PMCID: PMC2149274  PMID: 6932949

Abstract

Drug delivery to tumours and the accessibility of tumour cells to drugs remains a problem of foremost importance and is affected by many factors. We will discuss models we have developed for drug delivery from tumour capillaries to tumour cells, and drug delivery from well perfused, well oxygenated tumour regions to less well perfused hypoxic regions in terms of computer simulation of drug delivery for the anticancer agent BCNU and the hypoxic cell radiosensitizer misonidazole.

Full text

PDF
74

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Levin V. A., Kabra P. A., Freeman-Dove M. A. Relationship of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) pharmacokinetics of uptake, distribution, and tissue/plasma partitioning in rat organs and intracerebral tumors. Cancer Chemother Pharmacol. 1978;1(4):233–242. doi: 10.1007/BF00257156. [DOI] [PubMed] [Google Scholar]
  2. Levin V. A., Landahl H. D., Freeman-Dove M. A. The application of brain capillary permeability coefficient measurements to pathological conditions and the selection of agents which cross the blood-brain barrier. J Pharmacokinet Biopharm. 1976 Dec;4(6):499–519. doi: 10.1007/BF01064555. [DOI] [PubMed] [Google Scholar]
  3. Rosenblum M. L., Wheeler K. T., Wilson C. B., Barker M., Knebel K. D. In vitro evaluation of in vivo brain tumor chemotherapy with 1,3-bis(2-chloroethyl)-1-nitrosourea. Cancer Res. 1975 Jun;35(6):1387–1391. [PubMed] [Google Scholar]
  4. Wheeler K. T., Tel N., Williams M. E., Sheppard S., Levin V. A., Kabra P. M. Factors influencing the survival of rat brain tumor cells after in vitro treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea. Cancer Res. 1975 Jun;35(6):1464–1469. [PubMed] [Google Scholar]

Articles from The British Journal of Cancer. Supplement are provided here courtesy of Cancer Research UK

RESOURCES